Cinitapride (monotartrate)

Cinitapride monotartrate is a 5-HT1A and 5-HT4 agonist. Cinitapride monotartrate is also a 5-HT2A and D2 antagonist. Cinitapride monotartrate can be used for the research of functional dyspepsia[1][2].

Product Specifications

CAS Number

[1207859-16-2]

UNSPSC

12352005

Target

5-HT Receptor; Dopamine Receptor

Type

Reference compound

Related Pathways

GPCR/G Protein; Neuronal Signaling

Applications

Neuroscience-Neuromodulation

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/cinitapride-monotartrate.html

Solubility

10 mM in DMSO

Smiles

O=C(NC1CCN(CC2CC=CCC2)CC1)C3=CC([N+]([O-])=O)=C(N)C=C3OCC.O=C(O)[C@H](O)[C@@H](O)C(O)=O

Molecular Formula

C25H36N4O10

Molecular Weight

552.57

References & Citations

[1]Du Y, et al. Efficacy and safety of cinitapride in the treatment of mild to moderate postprandial distress syndrome-predominant functional dyspepsia. J Clin Gastroenterol. 2014 Apr;48 (4) :328-35.|[2]Alarcón de la Lastra C, et al. Effects of cinitapride on gastric ulceration and secretion in rats. Inflamm Res. 1998 Mar;47 (3) :131-6. |[3]Parthena MARTIN, et al. Compositions and methods for treating seizure disorders. Patent WO2018060732A2.